Dipharma Francis S.r.l. completes construction of new cGMP Suite in USA
Located in Kalamazoo (MI), the New GMP-compliant Kilolab and QC Laboratory will manage supply for clinical Phase 1 and early Phase 2.
Milan, Italy - Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announces today the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo (MI), USA.
The new state-of-the-art cGMP manufacturing suite strengthens Dipharma’s CDMO offering and completes the range of exclusive services, ensuring continuity across the whole lifecycle of Customers’ molecules, from preclinical to commercial stage.
CAS and Kalexsyn agree to a multi-year contract to offer unlimited SciFinder® access to researchers
Chemical Abstracts Service (CAS), the world’s authority for chemical information, announced today a three-year agreement for SciFinder®, the choice for chemistry research, with Kalexsyn, a Contract Research Organization (CRO) uniquely positioned to address the needs of the pharmaceutical and biotechnology communities.
Scientist-turned-entrepreneur Bob Gadwood of Kalexsyn is the next speaker in the WMU Entrepreneurship Forum series
Entrepreneurship was probably not the top thing on the minds of Kalamazoo-based scientists after Pfizer Inc. completed its buy-out of Pharmacia Corp. in 2003 and started to eliminate a lot of the research work done here.
But Bob Gadwood was among several Pharmacia/Pfizer scientists who enjoyed the work they did here, enjoyed living here and decided to take their skill sets and become entrepreneurs.